Antibody and Immunomodulatory Agents in the Treatment of Indolent Non-Hodgkin’s Lymphoma
To access this article, please choose from the options below
PII: S0037-1963(08)00005-X
doi:10.1053/j.seminhematol.2008.02.004
© 2008 Elsevier Inc. All rights reserved.
